tradingkey.logo
tradingkey.logo
Suchen

Balchem Corp

BCPC
Zur Watchlist hinzufügen
168.800USD
-0.090-0.05%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
5.42BMarktkapitalisierung
34.32KGV TTM

mehr Informationen über Balchem Corp Unternehmen

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Balchem Corp Informationen

BörsenkürzelBCPC
Name des UnternehmensBalchem Corp
IPO-datumJun 03, 1986
CEOHarris (Theodore L)
Anzahl der mitarbeiter1361
WertpapierartOrdinary Share
GeschäftsjahresendeJun 03
Addresse- -
Stadt- -
BörseNASDAQ OMX - NASDAQ BASIC
Land- -
Postleitzahl- -
Telefon- -
Website- -
BörsenkürzelBCPC
IPO-datumJun 03, 1986
CEOHarris (Theodore L)

Führungskräfte von Balchem Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Kathleen B. Fish
Ms. Kathleen B. Fish
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Balchem Corp?

Die fünf größten Anteilseigner von Balchem Corp sind: Mr. Theodore L. (Ted) Harris

Wie viele Institutionen halten Anteile an Balchem Corp (BCPC)?

Mit Stand vom 2026Q1 halten 741 Institutionen Anteile an Balchem Corp, mit einem Gesamtmarktwert von etwa 28.38M, was 88.34% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2011669.00 gestiegen.

Was ist die größte Einnahmequelle von Balchem Corp?

Am 2026Q1 erzielte das Geschäft mit Product Sales Revenue für Balchem Corp den höchsten Umsatz in Höhe von 1.04B, was 99.82% des Gesamtumsatzes entspricht.